NZ513981A - Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds - Google Patents

Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds

Info

Publication number
NZ513981A
NZ513981A NZ513981A NZ51398100A NZ513981A NZ 513981 A NZ513981 A NZ 513981A NZ 513981 A NZ513981 A NZ 513981A NZ 51398100 A NZ51398100 A NZ 51398100A NZ 513981 A NZ513981 A NZ 513981A
Authority
NZ
New Zealand
Prior art keywords
release
sustained
delivery
needleless syringe
bioactive compounds
Prior art date
Application number
NZ513981A
Other languages
English (en)
Inventor
Stephen Joseph Prestrelski
Terry Lee Burkoth
Gordon M Saul
Kevin John Brodbeck
Original Assignee
Powderject Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Res Ltd filed Critical Powderject Res Ltd
Publication of NZ513981A publication Critical patent/NZ513981A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
NZ513981A 1999-03-08 2000-03-08 Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds NZ513981A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12326499P 1999-03-08 1999-03-08
US26442799A 1999-03-08 1999-03-08
PCT/GB2000/000847 WO2000053160A1 (en) 1999-03-08 2000-03-08 Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds

Publications (1)

Publication Number Publication Date
NZ513981A true NZ513981A (en) 2004-02-27

Family

ID=26821383

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ513981A NZ513981A (en) 1999-03-08 2000-03-08 Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds

Country Status (6)

Country Link
EP (1) EP1158961A1 (ja)
JP (1) JP2002538195A (ja)
AU (1) AU770235B2 (ja)
CA (1) CA2364198A1 (ja)
NZ (1) NZ513981A (ja)
WO (1) WO2000053160A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3957400A (en) 1999-04-16 2000-11-02 Novo Nordisk A/S Dry, mouldable drug formulation
US6558348B2 (en) 2000-04-07 2003-05-06 Equidyne Systems, Inc. Low cost disposable needleless injector system for variable and fixed dose applications
GB0103620D0 (en) * 2001-02-14 2001-03-28 Prometic Biosciences Ltd Sterile composition and its preparation
EP1399132A1 (en) * 2001-06-08 2004-03-24 Powderject Vaccines, Inc. Production of hard, dense particles
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
AU2004246913A1 (en) * 2003-05-09 2004-12-23 Anges Mg, Inc. Needleless syringe having medical agent accommodated therein
JP2011504505A (ja) 2007-11-21 2011-02-10 デコード ジェネティクス イーエイチエフ 肺および心血管障害を治療するためのビアリールｐｄｅ４抑制剤
JP5501251B2 (ja) 2008-01-11 2014-05-21 アルバニー モレキュラー リサーチ， インコーポレイテッド Ｍｃｈ拮抗薬としての（１−アジノン）置換ピリドインドール類
WO2010059836A1 (en) 2008-11-20 2010-05-27 Decode Genetics Ehf Substituted aza-bridged bicyclics for cardiovascular and cns disease
BRPI1007350B8 (pt) 2009-01-26 2021-05-25 Israel Institute For Biological Res compostos espiro heterocíclicos bicíclicos
PT2525815E (pt) * 2010-01-24 2015-03-05 Novartis Ag Micropartículas de polímero biodegradável irradiadas

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925677A (en) * 1988-08-31 1990-05-15 Theratech, Inc. Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
TW404844B (en) * 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
EP0727984B1 (en) * 1993-11-18 2003-06-25 Sirtex Medical Limited Controlled release preparation
US5898271A (en) * 1996-04-25 1999-04-27 U.S. Philips Corporation Hollow cathodes with an I-beam or C-beam cross section for a plasma display device
GB9612629D0 (en) * 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
EP0991403B1 (en) * 1997-01-30 2003-04-02 Chiron Corporation Use of microparticles with adsorbed antigen to stimulate immune responses
US6656508B2 (en) * 1997-04-17 2003-12-02 Amgen Inc. Sustained-release alginate gels
GB9819272D0 (en) * 1998-09-03 1998-10-28 Andaris Ltd Microparticles
DE69925293T2 (de) * 1998-10-01 2006-01-26 Powderject Research Ltd. Sprühbeschichtete mikropartikel für nadellose spritzen
PT1146861E (pt) * 1999-02-03 2005-10-31 Powderject Res Ltd Formulacoes de particulas de hidrogel

Also Published As

Publication number Publication date
EP1158961A1 (en) 2001-12-05
AU770235B2 (en) 2004-02-19
AU2931200A (en) 2000-09-28
WO2000053160A1 (en) 2000-09-14
CA2364198A1 (en) 2000-09-14
JP2002538195A (ja) 2002-11-12

Similar Documents

Publication Publication Date Title
ZA9811843B (en) Derivatized carbohydrates compositions comprised thereof and methods for use thereof
BG102228A (en) Medicamentous form with controlled release of slightly soluble medicamentous substances
IL114596A (en) Pharmaceutical compositions containing an active substance blended with a carrier process for preparation thereof and their use for preparation of inhalated drugs
BR9911070A (pt) Sistema de liberação de droga compreendendo uma matéria-prima de medicamento sólido acentuadamente compacto
AU2001236207A1 (en) Powder formulation
WO2003103637A3 (en) MODIFIED RELEASE MULTIPLE UNIT DRUG DELIVERY SYSTEMS
ES2243229T3 (es) Formulaciones de particulas de hidrogel.
CA2195119A1 (en) Formulations and methods for providing prolonged local anesthesia
NZ513981A (en) Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
EP1941868A3 (en) Improvements in or relating to the delivery of oral drugs
WO2001043749A3 (en) Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
EP2298279A3 (en) Pharmaceutical compositions for inhalation
MXPA02010213A (es) Mejoras en, o relacionadas con formulaciones para usarse en aparatos inhiladores.
CA2125685A1 (en) Powders for inhalation and process for preparing them
DE69432025T2 (de) Formulierungen mit verzögerter freisetzung zur abgabe von metoprolol über 24 stunden
EP0693924A4 (en) METHODS OF ADMINISTRATION -i (IN VIVO) OF BIOLOGICAL SUBSTANCES AND COMPOSITIONS USED IN SUCH METHODS
AP2002002410A0 (en) Hydrodynamically Balancing Oral Drug Delivery System
IL142276A0 (en) Spray coated microparticles for use in needleless syringes
MXPA02006518A (es) Aerosol de gota liquida de gamma -ifn y metodo.
ATE364381T1 (de) Formulierungen zur verwendung in inhalationsvorrichtungen
UA66812C2 (uk) Препаративна форма лікарського засобу із регульованим вивільненням активної речовини
PL336658A1 (en) Stabilised tilbone compositions
SE9704400D0 (sv) Porous inorganic particles as carriers for drug substances
HK1038310A1 (en) Compositions and methods for treating intracellular infections.

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
RENW Renewal (renewal fees accepted)